KR100602826B1 - 1-알킬-4,5-디페닐이미다졸계의 신규의 화합물 및 진정제로서의 이의 용도 - Google Patents

1-알킬-4,5-디페닐이미다졸계의 신규의 화합물 및 진정제로서의 이의 용도 Download PDF

Info

Publication number
KR100602826B1
KR100602826B1 KR1020037013961A KR20037013961A KR100602826B1 KR 100602826 B1 KR100602826 B1 KR 100602826B1 KR 1020037013961 A KR1020037013961 A KR 1020037013961A KR 20037013961 A KR20037013961 A KR 20037013961A KR 100602826 B1 KR100602826 B1 KR 100602826B1
Authority
KR
South Korea
Prior art keywords
diphenylimidazole
delete delete
composition
alkyl
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020037013961A
Other languages
English (en)
Korean (ko)
Other versions
KR20040007508A (ko
Inventor
갈레쟝-밥띠스뜨
달꼬마리아
마에얀
뒤마쟈끌린
Original Assignee
로레알
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로레알 filed Critical 로레알
Publication of KR20040007508A publication Critical patent/KR20040007508A/ko
Application granted granted Critical
Publication of KR100602826B1 publication Critical patent/KR100602826B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
KR1020037013961A 2001-04-24 2002-04-24 1-알킬-4,5-디페닐이미다졸계의 신규의 화합물 및 진정제로서의 이의 용도 Expired - Fee Related KR100602826B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/05497 2001-04-24
FR0105497A FR2823747B1 (fr) 2001-04-24 2001-04-24 Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires
PCT/FR2002/001411 WO2002085863A1 (fr) 2001-04-24 2002-04-24 Composes de la famille des 3-alkyl-(4, 5 diphenyl-imidazol-1-yl) et leur utilisation comme apaisants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020067005892A Division KR100667647B1 (ko) 2001-04-24 2002-04-24 1-알킬-4,5-디페닐이미다졸계의 신규의 화합물 및진정제로서의 이의 용도

Publications (2)

Publication Number Publication Date
KR20040007508A KR20040007508A (ko) 2004-01-24
KR100602826B1 true KR100602826B1 (ko) 2006-07-19

Family

ID=8862628

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020037013961A Expired - Fee Related KR100602826B1 (ko) 2001-04-24 2002-04-24 1-알킬-4,5-디페닐이미다졸계의 신규의 화합물 및 진정제로서의 이의 용도
KR1020067005892A Expired - Fee Related KR100667647B1 (ko) 2001-04-24 2002-04-24 1-알킬-4,5-디페닐이미다졸계의 신규의 화합물 및진정제로서의 이의 용도

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020067005892A Expired - Fee Related KR100667647B1 (ko) 2001-04-24 2002-04-24 1-알킬-4,5-디페닐이미다졸계의 신규의 화합물 및진정제로서의 이의 용도

Country Status (7)

Country Link
US (1) US20040192928A1 (https=)
EP (1) EP1385827A1 (https=)
JP (1) JP2004528333A (https=)
KR (2) KR100602826B1 (https=)
CN (1) CN1330637C (https=)
FR (1) FR2823747B1 (https=)
WO (1) WO2002085863A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140227208A1 (en) * 2013-02-08 2014-08-14 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating mechanically-induced skin inflammation
CN108752663B (zh) * 2018-04-23 2021-03-26 龙岩学院 一种纳米蜂胶负载碳酸钙空心微球/天然胶乳抗菌复合膜的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3258466A (en) * 1961-12-07 1966-06-28 Kawakami Iwao 1-hydroxyethyl-4, 5-diphenylimidazole
GB1182551A (en) * 1967-03-01 1970-02-25 Teikoku Hormone Mfg Co Ltd Substituted Diphenyl Imidazoles and their production and use
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
US3929807A (en) * 1971-05-10 1975-12-30 Ciba Geigy Corp 2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
US3759946A (en) * 1971-09-20 1973-09-18 Teikoku Hormone Mfg Co Ltd 1-aryloxy-4,5-diphenylimidazoles
US4182769A (en) * 1977-02-09 1980-01-08 E. I. Du Pont De Nemours And Company Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones
KR100291112B1 (ko) * 1992-02-11 2001-09-17 더 존스 홉킨스 유니버시티 코엔자임에이-독립성트랜스아실라제및혈소판활성화인자억제제
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FR2823747B1 (fr) 2003-05-23
FR2823747A1 (fr) 2002-10-25
KR20040007508A (ko) 2004-01-24
KR20060032667A (ko) 2006-04-17
JP2004528333A (ja) 2004-09-16
KR100667647B1 (ko) 2007-01-12
EP1385827A1 (fr) 2004-02-04
WO2002085863A1 (fr) 2002-10-31
US20040192928A1 (en) 2004-09-30
CN1516692A (zh) 2004-07-28
CN1330637C (zh) 2007-08-08

Similar Documents

Publication Publication Date Title
EP0770376B1 (fr) Utilisation d'un antagoniste de substance P dans une composition topique comme agent antitranspirant
JP2999163B2 (ja) ６位が置換されたピリミジン−３−オキシド誘導体からなるチロシナーゼ刺激剤とこれを含有する組成物
DE69626433T2 (de) Verwendung mindestens eines in 6-Stellung substitutierten Pirimidinderivats in einer Zusammensetzung als Cyclooxygenase-Aktivator und/oder Cyclooxygenase-Stabilisator
CN104507455B (zh) 用于干性皮肤的化合物以及抗衰老应用
JP3108410B2 (ja) 新規な２−アミノ−４−アルキルアミノピリミジン−３−オキシド類とそれを含有する組成物
DE60313791T2 (de) Zusammensetzung für die Haarbehandlung, die ein Styrolpyrazol enthält
JPH11228525A (ja) Ｎ−アリール−２−ヒドロキシアルキルアミドから誘導された新規化合物
JP2003063984A (ja) Ｎ−アシルアミノアミドファミリーのエラスターゼ阻害剤と少なくとも１種の抗真菌剤又は少なくとも１種の抗菌剤の組み合わせを含む化粧品用又は皮膚用組成物
KR100602826B1 (ko) 1-알킬-4,5-디페닐이미다졸계의 신규의 화합물 및 진정제로서의 이의 용도
KR100814648B1 (ko) 1-알킬 4,5-디페닐-이미다졸계의 화합물 및 진정제로서의그의 용도
JPH03112912A (ja) 化粧料組成物
JP3715170B2 (ja) ベンジルアミノジアセトアミドファミリーの新規化合物、該化合物の組成物、製造方法及び用途
US6057351A (en) Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetic and pharmaceuticals
JP2004534069A (ja) Ｎｏ−シンターゼインヒビターとその用途
JP2005501818A (ja) Ｎｏ−シンターゼインヒビターとしての２−ヘキサデカン酸アスコルビル
JPS6344511A (ja) 養毛剤

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

A107 Divisional application of patent
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20090713

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20090713